UNISYS CORPORATION INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Unisys Investors of a Class Action Lawsuit and Upcoming Deadline
02 déc. 2022 21h10 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Unisys Corporation (“Unisys” or the “Company”) (NYSE:...
Provident Bancorp Investor Alert: Kaplan Fox Investigates Provident Bancorp
25 nov. 2022 11h56 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Provident Bancorp, Inc. (“Provident” or “Company”)...
Professional Diversity Network, Inc. Announces Third Quarter Results
13 nov. 2020 08h15 HE
|
Professional Diversity Network, Inc.
CHICAGO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (NASDAQ:IPDN), (“IPDN” or the “Company”), a global developer and operator of online and in-person networks that...
Meso Numismatics Files 10-Q - Hosts Interview Featuring Green Pay Executive Team
28 août 2019 13h51 HE
|
Meso Numismatics, Inc.
LAS VEGAS, NV, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (OTC: MSSV), a technology and numismatic company specializing in the...
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
09 août 2019 08h00 HE
|
VBI Vaccines, Inc.
Positive top-line data from PROTECT Phase 3 for Sci-B-Vac®, trivalent hepatitis B vaccine, announced June 2019 – top-line data from second Phase 3 study, CONSTANT, expected around year-end 2019ASCO...
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
09 nov. 2018 07h00 HE
|
VBI Vaccines, Inc.
-- Completion of vaccination and enrollment in Sci-B-Vac® PROTECT and CONSTANT Phase 3 studies, respectively -- -- Encouraging early immunologic data observed in Phase 1/2a study of...
VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update
26 juil. 2018 07h00 HE
|
VBI Vaccines, Inc.
-- Pivotal Phase 3 program for Sci-B-Vac® Hepatitis B vaccine continues to advance towards topline data expected mid-year 2019 -- -- Positive safety and immunogenicity data from Phase 1 study of...
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014
10 nov. 2014 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...
Recovery Energy, Inc. Announces the Filing of Its First Quarter Report on Form 10-Q
14 mai 2013 16h37 HE
|
Recovery Energy
DENVER, May 14, 2013 (GLOBE NEWSWIRE) -- Recovery Energy, Inc. (Nasdaq:RECV), an independent oil and gas exploration and production company with operations and assets in the Denver-Julesburg Basin,...
Aspire International Announces Intent to File All Quarterly Reports and Annual Report for 2011
18 avr. 2012 11h27 HE
|
Aspire International
TORONTO, April 18, 2012 (GLOBE NEWSWIRE) -- Aspire International Inc. (OTC:APIT) announced today that it expects to file all completed SEC Form 10-Q Quarterly Reports as well as its SEC From 10-K...